DE602005017391D1 - Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen - Google Patents

Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen

Info

Publication number
DE602005017391D1
DE602005017391D1 DE602005017391T DE602005017391T DE602005017391D1 DE 602005017391 D1 DE602005017391 D1 DE 602005017391D1 DE 602005017391 T DE602005017391 T DE 602005017391T DE 602005017391 T DE602005017391 T DE 602005017391T DE 602005017391 D1 DE602005017391 D1 DE 602005017391D1
Authority
DE
Germany
Prior art keywords
treatment
manlam
amino acid
molecule
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017391T
Other languages
English (en)
Inventor
Herve Bercovier
Ayelet Barenholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of DE602005017391D1 publication Critical patent/DE602005017391D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/42—Details of probe positioning or probe attachment to the patient
    • A61B8/4209—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames
    • A61B8/4227—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames characterised by straps, belts, cuffs or braces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
DE602005017391T 2004-06-24 2005-06-23 Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen Active DE602005017391D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58222104P 2004-06-24 2004-06-24
PCT/IL2005/000674 WO2006001011A1 (en) 2004-06-24 2005-06-23 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation

Publications (1)

Publication Number Publication Date
DE602005017391D1 true DE602005017391D1 (de) 2009-12-10

Family

ID=34972438

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017391T Active DE602005017391D1 (de) 2004-06-24 2005-06-23 Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen

Country Status (5)

Country Link
US (1) US8147837B2 (de)
EP (1) EP1761631B1 (de)
AT (1) ATE447021T1 (de)
DE (1) DE602005017391D1 (de)
WO (1) WO2006001011A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119780B2 (en) 2006-06-02 2012-02-21 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
US20080248508A1 (en) * 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
JP6401702B2 (ja) 2012-09-07 2018-10-10 ザ・ガバナーズ・オブ・ザ・ユニバーシティー オブ・アルバータ 炎症性肝疾患の診断のための方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696561B1 (en) * 1909-07-09 2004-02-24 Basf Aktiengesellschaft Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
EP0967279B1 (de) 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
WO2003049752A2 (en) 2001-12-11 2003-06-19 Institut Pasteur Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation

Also Published As

Publication number Publication date
WO2006001011A1 (en) 2006-01-05
US20080318868A1 (en) 2008-12-25
ATE447021T1 (de) 2009-11-15
EP1761631B1 (de) 2009-10-28
US8147837B2 (en) 2012-04-03
EP1761631A1 (de) 2007-03-14

Similar Documents

Publication Publication Date Title
ATE536369T1 (de) Im wesentlichen ph-wert-unabhängigerweise an serumproteine bindende aminosäuresequenzen, verbindungen, die diese enthalten, und deren verwendung
Gründemann et al. Do plant cyclotides have potential as immunosuppressant peptides?
MA29836B1 (fr) Proteines de fusion avec l'albumine
MX353319B (es) Composiciones y metodos relacionados con anticuerpos del receptor de glucagon.
BRPI0403964A (pt) Formulações lìquidas estáveis, artigo manufaturado e métodos de tratamento de disfunção mediada por ige
NO20054769L (no) Substituerte fenylalkansyrer
DE602007006010D1 (de) Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
ATE399014T1 (de) Nukleinsäuren zur behandlung von erkrankungen im zusammenhang mit hmgb1
DK1347730T3 (da) Rekombinante anti-CD30-antistoffer og anvendelser deraf
DK1969003T3 (da) Anvendelser af et neurotrofisk faktor-protein
ATE527353T1 (de) Pdgf-bindendes polypeptid aus protein a
DE602005021072D1 (de) Adzyme und deren verwendungen
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
RU2013126581A (ru) Мутанты стрептокиназы и их ковалентно модифицированные формы
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
EA201290671A1 (ru) Антигенсвязывающие белки, специфические в отношении сывороточного амилоидного компонента р
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DE602005017391D1 (de) Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen
NO20081453L (no) Sammensetninger og fremgangsmater for diagnostisering og behandling av inflammasjon
Palmer et al. Comparing the use of magnetic beads with ultrafiltration for ancient dental calculus proteomics
Luo et al. Bioactive peptides and proteins from wasp venoms
ATE533776T1 (de) Analoge verbindungen analgetischer peptide, abgeleitet vom crotalus durissus terrificus schlangengift, ihre verwendungen, zusammensetzungen und verfahren ihrer herstellung und reinigung
ATE500840T1 (de) Verwendung von gilz-protein zur modulation einer antigenspezifischen immunantwort
GB0524884D0 (en) Improvements in or relating to organic compounds
WO2006029343A3 (en) Peptides that selectively home to heart vasculature and related conjugates and methods

Legal Events

Date Code Title Description
8364 No opposition during term of opposition